SEMA4C and breast cancer: In vitro, the knockdown of SEMA4C or the PlexinB2 receptor in BC cell lines representing the main molecular subtypes (MCF7, MDA-MB-231 and SKBR3) was associated with the inhibition of proliferation, an effect not observed in the normal mammary epithelial cell line, HMEC-hTERT.